- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00987324
Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis (ISAR-DESIRE-3)
Randomized Trial of Paclitaxel-Eluting Balloon, Paclitaxel-Eluting Stent and Plain Balloon Angioplasty for Restenosis in "-Limus"-Eluting Coronary Stents
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The use of drug-eluting stents (DES) has led to a drastic reduction of restenosis rates compared to bare metal stents (BMS), but 5% to 10% of patients receiving DES are still in need of revascularization of the treated vessel. Two important families of drugs are used for stent coating: paclitaxel belonging to the taxane family, and the "limus"-family such as sirolimus, everolimus, zotarolimus, biolimus A9 and pimecrolimus.
Data regarding the optimal treatment of in-DES-restenosis is very limited. Implanting a new DES for in-DES-restenosis has been reported to be associated with re-restenosis rates as high as 43%. Several recent well published studies have shown a substantial reduction of restenosis using paclitaxel-eluting balloons (PEB) for de-novo lesions and BMS-restenotic lesions.
The objective of this randomized trial is to assess the hypothesis, that PEB are non-inferior to paclitaxel-eluting-stents (PES) for restenosis in "limus"-eluting-stents (LES), and both, PEB and PES, are superior to plain angioplasty in patients with restenosis after initial LES implantation.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 4
Kontakter och platser
Studieorter
-
-
-
Bad Krozingen, Tyskland, 79189
- Herz-Zentrum
-
Munich, Tyskland, 80636
- Deutsches Herzzentrum
-
-
Bavaria
-
Munich, Bavaria, Tyskland, 81675
- 1. Med. Klinik, Klinikum rechts der Isar
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patients with ischemic symptoms or evidence of myocardial ischemia in the presence of ≥ 50% restenosis after prior implantation of LES in native coronary vessels.
- Written, informed consent by the patient or her/his legally-authorized representative for participation in the study.
- In women with childbearing potential a negative pregnancy test is mandatory.
Exclusion Criteria:
- Age < 18 years.
- Cardiogenic shock.
- Acute ST-elevation myocardial infarction within 48 hours from symptom onset.
- Target lesion located in the left main trunk or bypass graft.
- Target lesion located in small vessel (vessel size < 2.0 mm).
- Malignancies or other comorbid conditions (for example severe liver, renal and pancreatic disease) with life expectancy less than 12 months or that may result in protocol non-compliance.
- Severe renal insufficiency (glomerular filtration rate ≤ 30 ml/min).
- Contraindications to antiplatelet therapy, paclitaxel, stainless steel, cobalt, chrome.
- Pregnancy (present, suspected or planned) or positive pregnancy test.
- Previous enrollment in this trial.
- Patient's inability to fully comply with the study protocol.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Paclitaxel-eluting stent
Paclitaxel-eluting stent (Taxus)
|
Implantation of paclitaxel-eluting stent
|
Aktiv komparator: Plain Balloon
plain balloon angioplasty
|
Ryuijin, Trek
|
Experimentell: Paclitaxel-eluting balloon
SeQuent Please
|
Dilation with SeQuent Please (paclitaxel-eluting balloon)
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Percent in-segment diameter stenosis at follow-up angiography
Tidsram: 6-8 months
|
6-8 months
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
In-segment minimal luminal diameter
Tidsram: 6-8 months
|
6-8 months
|
In-segment binary angiographic restenosis
Tidsram: 6-8 months
|
6-8 months
|
Combined incidence of death or myocardial infarction
Tidsram: 1 and 2 years
|
1 and 2 years
|
Incidence of thrombosis
Tidsram: 1 and 2 years
|
1 and 2 years
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Julinda Mehilli, MD, Deutsches Herzzentrum Munich
- Studiestol: Adnan Kastrati, MD, Deutsches Herzzentrum
- Studierektor: Klaus Tiroch, MD, Deutsches Herzzentrum
Publikationer och användbara länkar
Allmänna publikationer
- Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009 Jun 16;119(23):2986-94. doi: 10.1161/CIRCULATIONAHA.108.839282. Epub 2009 Jun 1.
- Kufner S, Cassese S, Valeskini M, Neumann FJ, Schulz-Schupke S, Hoppmann P, Fusaro M, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA; ISAR-DESIRE 3 Investigators. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial. JACC Cardiovasc Interv. 2015 Jun;8(7):877-84. doi: 10.1016/j.jcin.2015.01.031. Epub 2015 May 20.
- Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz KL, Massberg S, Kastrati A; ISAR-DESIRE 3 investigators. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet. 2013 Feb 9;381(9865):461-7. doi: 10.1016/S0140-6736(12)61964-3. Epub 2012 Dec 1.
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- GE IDE NO. S02908
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Ischemi
-
University Hospital, Strasbourg, FranceAvslutadKärlkirurgi | Ischemi-reperfusion | Ischemi förkonditioneringFrankrike
-
Beytepe Murat Erdi Eker State HospitalAvslutadFrämre segmentets ischemi (diagnos)
-
The First Affiliated Hospital with Nanjing Medical...RekryteringHepatisk ischemiKina
-
Maastricht University Medical CenterOkändIschemi-reperfusionNederländerna
-
Aalborg University HospitalAvslutadAkut intestinal ischemi
-
Technische Universität DresdenRekrytering
-
Centre Hospitalier Universitaire de NiceAvslutad
-
Attikon HospitalUniversity Hospital of PatrasAvslutad
-
Beth Israel Deaconess Medical CenterIndragen
-
Hospices Civils de LyonAvslutad
Kliniska prövningar på Taxus stent
-
Associations for Establishment of Evidence in InterventionsAvslutad
-
Boston Scientific CorporationAvslutadKranskärlssjukdomFörenta staterna
-
Centre Chirurgical Marie LannelongueCentre Hospitalier Universitaire de Nice; University Hospital, Limoges; Hôpital... och andra samarbetspartnersAvslutadDiabetes | Kranskärlssjukdom | Kronisk total ocklusion av kransartär | Restenos | Vaskulära lesionerFrankrike
-
Aarhus University Hospital SkejbyOdense University Hospital; University of Copenhagen; University of AarhusAvslutadKranskärlssjukdom | Angina pectoris
-
Seoul National University HospitalB. Braun Melsungen AGOkänd
-
Institute of Cardiology, Warsaw, PolandOkändStenos i Saphenous Ven Graft, Drug Eluing StentPolen
-
French Cardiology SocietyBoston Scientific CorporationAvslutad
-
CID - Carbostent & Implantable DevicesAvslutadStabil angina | Instabil angina | Dokumenterad tyst ischemiFrankrike, Tyskland, Belgien, Italien
-
The Hospital District of SatakuntaAvslutadAkut hjärtinfarktFinland
-
Boston Scientific CorporationLabcoat, Ltd.AvslutadKranskärlssjukdomItalien